Use of nuclear material to therapeutically reprogram differentiated cells

Details for Australian Patent Application No. 2006210463 (hide)

Owner PrimeGen Biotech, LLC

Inventors Silva, Francisco J.; Sayre, Chauncey B.

Agent Spruson & Ferguson

Pub. Number AU-A-2006210463

PCT Pub. Number WO2006/084229

Priority 60/649,847 02.02.05 US; 11/060,131 16.02.05 US

Filing date 2 February 2006

Wipo publication date 10 August 2006

International Classifications

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/084229 Priority application(s): WO2006/084229

10 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210466-Permanent magnet flux module reciprocating engine and method

2006210461-Travel multiplier mechanisms for writing instruments